A Multicenter Randomized Trial of Continuous versus Intermittent β-Lactam Infusion in Severe Sepsis (Q40709270)

23 September 2017

title

A Multicenter Randomized Trial of Continuous versus Intermittent β-Lactam Infusion in Severe Sepsis (English)

1 reference

multicenter clinical trial

23 September 2017

main subject

0 references

0 references

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26200166%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

Joel M Dulhunty

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26200166%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

Joshua S. Davis

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26200166%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

Rinaldo Bellomo

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26200166%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

David L Paterson

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26200166%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

Sanjoy K. Paul

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26200166%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

Jeffrey Lipman

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26200166%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

6

Charles Gomersall

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26200166%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

11

Therese Starr

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26200166%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

4

Steven A R Webb

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26200166%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

7

Charudatt Shirwadkar

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26200166%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

8

Glenn M Eastwood

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26200166%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

author name string

John Myburgh

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26200166%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

BLING II Investigators for the ANZICS Clinical Trials Group *

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26200166%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

language of work or name

English

0 references

publication date

22 July 2015

1 reference

American Journal of Respiratory and Critical Care Medicine

23 September 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26200166%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

volume

192

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26200166%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26200166%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

page(s)

1298-1305

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26200166%20AND%20SRC:MED&resulttype=core&format=json

Antibiotic use and impact on outcome from bacteraemic critical illness: the BActeraemia Study in Intensive Care (BASIC).

14 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201505-0857OC

Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201505-0857OC

Antimicrobial pharmacodynamics: critical interactions of 'bug and drug'.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201505-0857OC

Continuous infusion of beta-lactams.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201505-0857OC

DALI: Defining Antibiotic Levels in Intensive Care Unit Patients: Are Current -Lactam Antibiotic Doses Sufficient for Critically Ill Patients?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201505-0857OC

A survey of beta-lactam antibiotics and vancomycin dosing strategies in intensive care units and general wards in Belgian hospitals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201505-0857OC

Pharmacokinetics of piperacillin-tazobactam: intermittent dosing versus continuous infusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201505-0857OC

Antibiotics in critically ill patients: a systematic review of the pharmacokinetics of β-lactams

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201505-0857OC

Meropenem dosing in critically ill patients with sepsis and without renal dysfunction: intermittent bolus versus continuous administration? Monte Carlo dosing simulations and subcutaneous tissue distribution.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201505-0857OC

Piperacillin penetration into tissue of critically ill patients with sepsis--bolus versus continuous administration?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201505-0857OC

Risk factors for target non-attainment during empirical treatment with β-lactam antibiotics in critically ill patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201505-0857OC

Killing of Pseudomonas aeruginosa during continuous and intermittent infusion of ceftazidime in an in vitro pharmacokinetic model

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201505-0857OC

Clinical cure of ventilator-associated pneumonia treated with piperacillin/tazobactam administered by continuous or intermittent infusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201505-0857OC

Clinical outcomes with extended or continuous versus short-term intravenous infusion of carbapenems and piperacillin/tazobactam: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201505-0857OC

Continuous infusion of beta-lactam antibiotics in severe sepsis: a multicenter double-blind, randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201505-0857OC

Continuous versus intermittent intravenous administration of antibiotics: a meta-analysis of randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201505-0857OC

A systematic review on clinical benefits of continuous administration of beta-lactam antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201505-0857OC

APACHE II: a severity of disease classification system

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201505-0857OC

Therapeutic drug monitoring of beta-lactams in critically ill patients: proof of concept

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201505-0857OC

Clinical and microbiological efficacy of continuous versus intermittent application of meropenem in critically ill patients: a randomized open-label controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201505-0857OC

Antimicrobial susceptibility pattern comparisons among intensive care unit and general ward Gram-negative isolates from the Meropenem Yearly Susceptibility Test Information Collection Program (USA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201505-0857OC

Meropenem by continuous versus intermittent infusion in ventilator-associated pneumonia due to gram-negative bacilli

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201505-0857OC

Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201505-0857OC

10.1164/RCCM.201505-0857OC

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26200166%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

1 reference